Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationCurrent Price
as of Dec 02, 2024$116.70
P/E Ratio
47.42
Market Cap
$14.2B
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.
Overview
Trading Information
Company